IHH Healthcare

Dr Tan See Leng

CEO, IHH Healthcare

Dr Tan See Leng is Managing Director and CEO of IHH Healthcare Berhad since January 2014 and is an Executive Director since 2012. He provides strategic direction and leadership for overall operations within IHH Healthcare (IHH) and its various subsidiaries. Dr Tan joined Parkway in 2004 as Chief Operating Officer of Mount Elizabeth Hospital and rose rapidly through the ranks. Under his stewardship, IHH has grown its footprint to 83 hospitals in 12 countries worldwide.

Dr Tan has over 25 years of experience in the healthcare industry. At the age of 27, he founded a private primary healthcare group and subsequently developed it to the second largest primary healthcare group in Singapore before successfully selling the company to one of the leading global health-plan providers. Over the years, he has held numerous ministerial advisory and medical committee appointments and has served on the Singapore Ministry of Health’s MediShield Life Review Committee.

A passionate supporter of improving healthcare provision through innovations and private-public collaboration, Dr Tan has guest lectured at the Harvard Business School’s healthcare management seminar series. He also provided advisory inputs as an expert panel member for Department of Health, National Health Services (UK). Dr Tan maintains active involvement in academia through board memberships and appointments such as Adjunct Assistant Professor of Duke-NUS Graduate Medical School Singapore, Office of Education and Advisory Board of Lee Kong Chian School of Business at Singapore Management University.

On the business front, he regularly represents regional business leadership on International and Regional Business Councils. Dr Tan was named Asia Innovator of the Year at the 14th CNBC Asia Business Leaders Awards (ABLA) 2015 and Best Executive in Malaysia at the 2016 Asiamoney Best Managed Companies Awards. In 2017, he won the ABLA Corporate Social Responsibility Award.